Esperion Therapeutics Stock Price on November 23, 2023
| ESPR Stock | USD 2.54 0.03 1.17% |
Below is the normalized historical share price chart for Esperion Therapeutics extending back to June 26, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Esperion Therapeutics stands at 2.54, as last reported on the 28th of November, with the highest price reaching 2.61 and the lowest price hitting 2.46 during the day.
If you're considering investing in Esperion Stock, it is important to understand the factors that can impact its price. Esperion Therapeutics appears to be unstable, given 3 months investment horizon. Esperion Therapeutics secures Sharpe Ratio (or Efficiency) of 0.14, which denotes the company had a 0.14% return per unit of risk over the last 3 months. By reviewing Esperion Therapeutics' technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please utilize Esperion Therapeutics' Mean Deviation of 3.4, coefficient of variation of 683.68, and Downside Deviation of 3.99 to check if our risk estimates are consistent with your expectations.
At this time, Esperion Therapeutics' Common Stock Total Equity is relatively stable compared to the past year. As of 11/28/2024, Common Stock Shares Outstanding is likely to grow to about 108.3 M, though Treasury Stock is likely to grow to (47 M). . As of 11/28/2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 2.52. Esperion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of June 2013 | 200 Day MA 2.2161 | 50 Day MA 2.0442 | Beta 0.954 |
Esperion |
Sharpe Ratio = 0.1353
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ESPR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.61 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.62 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Esperion Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Esperion Therapeutics by adding it to a well-diversified portfolio.
Price Book 98.4236 | Enterprise Value Ebitda (3.86) | Price Sales 1.7139 | Shares Float 195.6 M | Wall Street Target Price 7.5083 |
Esperion Therapeutics Main Headline on 22nd of November 2023
Sale by Nicole Vitullo of 9326 shares of Esperion Therapeuti... by Nicole Vitullo
Filed transaction by Esperion Therapeutics Inc director. General open market or private sale of non-derivative or derivative security
Esperion Therapeutics Valuation on November 23, 2023
It is possible to determine the worth of Esperion Therapeutics on a given historical date. On November 23, 2023 Esperion was worth 1.21 at the beginning of the trading date compared to the closed value of 1.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Esperion Therapeutics stock. Still, in general, we apply an absolute valuation method to find Esperion Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Esperion Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Esperion Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.23 | 1.26 | 1.15 | 1.19 | 2,541,785 | |
11/22/2023 | 1.21 | 1.26 | 1.17 | 1.21 | 2,965,165 |
| 1.24 | 1.33 | 1.23 | 1.25 | 2,382,265 |
| Backtest Esperion Therapeutics | | | Esperion Therapeutics History | | | Esperion Therapeutics Valuation | Previous | Next |
Esperion Therapeutics Trading Date Momentum on November 23, 2023
| On November 24 2023 Esperion Therapeutics was traded for 1.25 at the closing time. The top price for the day was 1.33 and the lowest listed price was 1.23 . The trading volume for the day was 2.4 M. The trading history from November 24, 2023 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 3.31% . The overall trading delta against the current closing price is 19.01% . |
Esperion Therapeutics Fundamentals Correlations and Trends
By evaluating Esperion Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Esperion Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Esperion financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Esperion Therapeutics Stock history
Esperion Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Esperion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Esperion Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Esperion Therapeutics stock prices may prove useful in developing a viable investing in Esperion Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 103.1 M | 108.3 M | |
| Net Loss | -210.3 M | -220.8 M |
Esperion Therapeutics Quarterly Net Working Capital |
|
Esperion Therapeutics Stock Technical Analysis
Esperion Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Esperion Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Esperion Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Esperion Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Esperion Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Esperion Therapeutics shares will generate the highest return on investment. By undertsting and applying Esperion Therapeutics stock market strength indicators, traders can identify Esperion Therapeutics entry and exit signals to maximize returns
Esperion Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Esperion Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Esperion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Esperion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1201 | |||
| Jensen Alpha | 0.6375 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.1345 | |||
| Treynor Ratio | 4.12 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Esperion Stock Analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.